In a meta-analysis that included four RCTs (published from 2020 to 2023), involving 1035 patients with type II diabetes mellitus, Saleem compared insulin Glargine U-100 and insulin Icodec. The gene discussed is INS; the disease is type 2 diabetes mellitus.